Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials

Background: Emerging data suggest that outcomes for advanced hepatocellular carcinoma (HCC) treated with sorafenib may have improved over time. We aimed to provide robust, time-to-event estimates of survival outcomes for sorafenib in advanced HCC. Summary: In this systematic review and individual pa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Liver cancer (Basel ) 2023-10, Vol.12 (5), p.445-456
Hauptverfasser:	Tan, Darren Jun Hao, Tang, Ansel Shao Pin, Lim, Wen Hui, Ng, Cheng Han, Nah, Benjamin, Fu, Clarissa, Xiao, Jieling, Koh, Benjamin, Tay, Phoebe Wen Lin, Tan, Eunice X, Teng, Margaret, Syn, Nicholas, Muthiah, Mark D, Tamaki, Nobuharu, Lee, Sung Won, Kim, Beom Kyung, Yau, Thomas, Vogel, Arndt, Loomba, Rohit, Huang, Daniel Q.
Format:	Artikel
Sprache:	eng
Schlagworte:	Bias Cancer therapies Clinical trials Demographics Generalized linear models Hepatitis Inhibitor drugs Liver cancer Liver diseases Meta-Analysis Patients Survival analysis Targeted cancer therapy Trends
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!